Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | KSQ-4279 |
Synonyms | |
Therapy Description |
KSQ-4279 inhibits USP1, potentially decreasing cancer cell proliferation and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr ND01). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KSQ-4279 | KSQ 4279|KSQ4279 | USP1 inhibitor 7 | KSQ-4279 inhibits USP1, potentially decreasing cancer cell proliferation and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr ND01). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05240898 | Phase I | KSQ-4279 | A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors | Recruiting | USA | 0 |